New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics ...

Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a ...

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical utility study demonstrating that the PromarkerD blood test provides actionable ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

Kidney disease can cause facial swelling, itchiness, and blisters. Symptoms can depend on the stage of kidney disease. Uremic leontiasis ossea is a rare and severe complication of advanced kidney ...